Results 271 to 280 of about 310,970 (312)
Some of the next articles are maybe not open access.
Nature Reviews Genetics, 2004
Robustness is a ubiquitously observed property of biological systems. It is considered to be a fundamental feature of complex evolvable systems. It is attained by several underlying principles that are universal to both biological organisms and sophisticated engineering systems.
openaire +2 more sources
Robustness is a ubiquitously observed property of biological systems. It is considered to be a fundamental feature of complex evolvable systems. It is attained by several underlying principles that are universal to both biological organisms and sophisticated engineering systems.
openaire +2 more sources
Dermatologic Clinics
Biologic therapies targeting tumor necrosis factor alpha (TNF-α) (infliximab, adalimumab, certolizumab, etanercept), the p40 subunit shared by IL-12 and IL-23 (ustekinumab), the p19 subunit of IL-23 (guselkumab, tildrakizumab, risankizumab), IL-17A (secukinumab, ixekizumab), IL-17-RA (brodalumab) and both IL-17A and IL-17F (bimekizumab) have ...
Anthony Mitchel, Wride +4 more
openaire +2 more sources
Biologic therapies targeting tumor necrosis factor alpha (TNF-α) (infliximab, adalimumab, certolizumab, etanercept), the p40 subunit shared by IL-12 and IL-23 (ustekinumab), the p19 subunit of IL-23 (guselkumab, tildrakizumab, risankizumab), IL-17A (secukinumab, ixekizumab), IL-17-RA (brodalumab) and both IL-17A and IL-17F (bimekizumab) have ...
Anthony Mitchel, Wride +4 more
openaire +2 more sources
Cancer Chemotherapeutic and Biologic Agents
Ca-A Cancer Journal for Clinicians, 1993Leonard Sadoff
exaly +2 more sources
Plant Cell-Based Drug Delivery Enhances Affordability of Biologics
Nature Biotechnology, 2023Roland W Herzog +2 more
exaly
Neuroblastoma: A Clinical Challenge and Biologic Puzzle
Ca-A Cancer Journal for Clinicians, 1995Katherine K Matthay
exaly
Cancer Chemotherapeutic and Biologic Agents
Ca-A Cancer Journal for Clinicians, 1991I H Krakoff
exaly